Our main goal was not only to define the diagnostic power of these miRNAs but also to evaluate whether the deregulation of these molecules could depend on specific clinical features that characterise HF patients (hormonal deficiencies in association with EF, NT-proBNP, and NYHA classes). This evidence concerns the gene NPPB and hydrops fetalis.